Clinical trial
A Multicenter, Open-Label, Noncomparative Phase 1-2 Clinical And Pharmacokinetic Study Of Oral PD 0325901 In Patients With Advanced Cancer
NCT00147550 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Open-Label, Noncomparative Phase 1-2 Clinical And Pharmacokinetic Study Of Oral PD 0325901 In Patients With Advanced Cancer
- Lead sponsor
- Pfizer
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- February 29, 2004
- Completion date
- July 31, 2013
- Enrollment
- 79 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.